🇺🇸 FDA
Patent

US 7785886

Methods and reagents for modulating cholesterol levels

granted A61KA61K2039/53A61K38/00

Quick answer

US patent 7785886 (Methods and reagents for modulating cholesterol levels) held by Xenon Pharmaceuticals Inc. expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K2039/53, A61K38/00, A61K48/00, A61P